{"id":{"repo_id":"vt","oai_identifier":"oai:vtechworks.lib.vt.edu:10919/40828"},"canonical_url":"https://search.dev.ndltd.org/etd/vt/oai:vtechworks.lib.vt.edu:10919/40828","repository":{"repo_id":"vt","name":"Virginia Tech","base_url":"https://vtechworks.lib.vt.edu/oai/request"},"display":{"title":"The effect of boron supplementation and oral contraceptives on mineral status and hormone status of college female athletes and non-atheletes","abstract":"Twenty-nine college females, aged 18-29, participated in a six month boron supplementation protocol to evaluate mineral and hormone status of athletes and non-athletes. All subjects were classified into activity and oral contraceptive groups as follows: athletes (n=16), non-athletes (n=13), oral contraceptives (n=12), and no oral contraceptives (n=17). Subjects were randomly assigned to receive a placebo or 3 mg of boron per day. Subjects' maximal oxygen consumption (VO₂max) was assessed as a baseline measurement and was used to confirm a difference between activity groups. Body fat, height, bone mineral density, and serum calcitonin and parathyroid also were baseline measurements. Subjects were measured at baseline and six months for the following: dietary intake, body weight, serum levels of 17-f-estradiol, progesterone, and testosterone, and plasma and urine levels of calcium, phosphorus, magnesium, and boron. Athletes had a Significantly greater VO₂max (p < 0.01) than did non-athletes. Subjects taking oral contraceptives had significantly lower serum estradiol (p < 0.05) as compared to subjects not taking oral contraceptives. Boron supplemented non-athletes had a significantly greater change in plasma calcium levels (p < 0.05) as compared to boron supplemented athletes, although the athletes had a significantly higher plasma calcium level (p < 0.05) at the baseline measurement. Control subjects (n=6) had a significantly greater change in dietary carbohydrate (p < 0.01) and protein intake (p < 0.05) as compared to subjects taking boron (n=23). Boron supplementation did not appear to significantly influence any of the parameters measured. However, boron supplementation combined with activity appeared to influence plasma calcium, while serum estradiol may be influenced by oral contraceptives.","abstract_html":"Twenty-nine college females, aged 18-29, participated in a six month boron supplementation protocol to evaluate mineral and hormone status of athletes and non-athletes. All subjects were classified into activity and oral contraceptive groups as follows: athletes (n=16), non-athletes (n=13), oral contraceptives (n=12), and no oral contraceptives (n=17). Subjects were randomly assigned to receive a placebo or 3 mg of boron per day. Subjects&#x27; maximal oxygen consumption (VO₂max) was assessed as a baseline measurement and was used to confirm a difference between activity groups. Body fat, height, bone mineral density, and serum calcitonin and parathyroid also were baseline measurements. Subjects were measured at baseline and six months for the following: dietary intake, body weight, serum levels of 17-f-estradiol, progesterone, and testosterone, and plasma and urine levels of calcium, phosphorus, magnesium, and boron. Athletes had a Significantly greater VO₂max (p &lt; 0.01) than did non-athletes. Subjects taking oral contraceptives had significantly lower serum estradiol (p &lt; 0.05) as compared to subjects not taking oral contraceptives. Boron supplemented non-athletes had a significantly greater change in plasma calcium levels (p &lt; 0.05) as compared to boron supplemented athletes, although the athletes had a significantly higher plasma calcium level (p &lt; 0.05) at the baseline measurement. Control subjects (n=6) had a significantly greater change in dietary carbohydrate (p &lt; 0.01) and protein intake (p &lt; 0.05) as compared to subjects taking boron (n=23). Boron supplementation did not appear to significantly influence any of the parameters measured. However, boron supplementation combined with activity appeared to influence plasma calcium, while serum estradiol may be influenced by oral contraceptives.","abstract_has_math":false,"creators":["Ward, Candice Lyn"],"institution":"Virginia Tech","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Human Nutrition and Foods","degree_department":"Human Nutrition and Foods","school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1994,"date_issued":"1994","date_published":"1994","updated_at":"2026-07-22T22:20:20Z","subjects":[],"languages":["en"],"rights":["In Copyright"],"rights_urls":["http://rightsstatements.org/vocab/InC/1.0/"],"identifier_entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["etd-01312009-063054"],"render_values":[{"text":"etd-01312009-063054","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/10919/40828","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.department","label":"Department","values":["Human Nutrition and Foods"]},{"key":"dc:creator","label":"Author","values":["Ward, Candice Lyn"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-03-14T21:27:59Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-03-14T21:27:59Z","2009-01-31"]},{"key":"dc:date.issued","label":"Date","values":["1994"]},{"key":"dc:publisher","label":"Institution","values":["Virginia Tech"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.dcmitype","label":"Dc Type Dcmitype","values":["Text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Human Nutrition and Foods"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Virginia Polytechnic Institute and State University"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://rightsstatements.org/vocab/InC/1.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["etd-01312009-063054"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/10919/40828"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Twenty-nine college females, aged 18-29, participated in a six month boron supplementation protocol to evaluate mineral and hormone status of athletes and non-athletes. All subjects were classified into activity and oral contraceptive groups as follows: athletes (n=16), non-athletes (n=13), oral contraceptives (n=12), and no oral contraceptives (n=17). Subjects were randomly assigned to receive a placebo or 3 mg of boron per day. Subjects' maximal oxygen consumption (VO₂max) was assessed as a baseline measurement and was used to confirm a difference between activity groups. Body fat, height, bone mineral density, and serum calcitonin and parathyroid also were baseline measurements. Subjects were measured at baseline and six months for the following: dietary intake, body weight, serum levels of 17-f-estradiol, progesterone, and testosterone, and plasma and urine levels of calcium, phosphorus, magnesium, and boron. Athletes had a Significantly greater VO₂max (p < 0.01) than did non-athletes. Subjects taking oral contraceptives had significantly lower serum estradiol (p < 0.05) as compared to subjects not taking oral contraceptives. Boron supplemented non-athletes had a significantly greater change in plasma calcium levels (p < 0.05) as compared to boron supplemented athletes, although the athletes had a significantly higher plasma calcium level (p < 0.05) at the baseline measurement. Control subjects (n=6) had a significantly greater change in dietary carbohydrate (p < 0.01) and protein intake (p < 0.05) as compared to subjects taking boron (n=23). Boron supplementation did not appear to significantly influence any of the parameters measured. However, boron supplementation combined with activity appeared to influence plasma calcium, while serum estradiol may be influenced by oral contraceptives."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science"]},{"key":"dc:format.medium","label":"Dc Format Medium","values":["BTD"]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["The effect of boron supplementation and oral contraceptives on mineral status and hormone status of college female athletes and non-atheletes"]}]}],"canonical_facts":{"dc:contributor.department":["Human Nutrition and Foods"],"dc:creator":["Ward, Candice Lyn"],"dc:date.accessioned":["2014-03-14T21:27:59Z"],"dc:date.available":["2014-03-14T21:27:59Z","2009-01-31"],"dc:date.issued":["1994"],"dc:description.abstract":["Twenty-nine college females, aged 18-29, participated in a six month boron supplementation protocol to evaluate mineral and hormone status of athletes and non-athletes. All subjects were classified into activity and oral contraceptive groups as follows: athletes (n=16), non-athletes (n=13), oral contraceptives (n=12), and no oral contraceptives (n=17). Subjects were randomly assigned to receive a placebo or 3 mg of boron per day. Subjects' maximal oxygen consumption (VO₂max) was assessed as a baseline measurement and was used to confirm a difference between activity groups. Body fat, height, bone mineral density, and serum calcitonin and parathyroid also were baseline measurements. Subjects were measured at baseline and six months for the following: dietary intake, body weight, serum levels of 17-f-estradiol, progesterone, and testosterone, and plasma and urine levels of calcium, phosphorus, magnesium, and boron. Athletes had a Significantly greater VO₂max (p < 0.01) than did non-athletes. Subjects taking oral contraceptives had significantly lower serum estradiol (p < 0.05) as compared to subjects not taking oral contraceptives. Boron supplemented non-athletes had a significantly greater change in plasma calcium levels (p < 0.05) as compared to boron supplemented athletes, although the athletes had a significantly higher plasma calcium level (p < 0.05) at the baseline measurement. Control subjects (n=6) had a significantly greater change in dietary carbohydrate (p < 0.01) and protein intake (p < 0.05) as compared to subjects taking boron (n=23). Boron supplementation did not appear to significantly influence any of the parameters measured. However, boron supplementation combined with activity appeared to influence plasma calcium, while serum estradiol may be influenced by oral contraceptives."],"dc:description.degree":["Master of Science"],"dc:format.medium":["BTD"],"dc:format.mimetype":["application/pdf"],"dc:identifier.other":["etd-01312009-063054"],"dc:identifier.uri":["http://hdl.handle.net/10919/40828"],"dc:language.iso":["en"],"dc:publisher":["Virginia Tech"],"dc:rights":["In Copyright"],"dc:rights.uri":["http://rightsstatements.org/vocab/InC/1.0/"],"dc:title":["The effect of boron supplementation and oral contraceptives on mineral status and hormone status of college female athletes and non-atheletes"],"dc:type":["Thesis"],"dc:type.dcmitype":["Text"],"thesis:degree_discipline":["Human Nutrition and Foods"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Virginia Polytechnic Institute and State University"]},"updated_at":"2026-07-22T22:20:20Z"}